PFA Intimation w.r.t Investor Call.
Awaiting price reaction for this filing.
Ajanta Pharma will release its Q4 FY2025 audited financial results on 30th April 2025 after the Board meeting. On the same day, the leadership team will host an earnings conference call at 1630 hrs IST, lasting about an hour, to discuss performance and take investor questions. Dial-in numbers are provided for participants in India, the USA, the UK, Hong Kong, and Singapore, along with a Diamond Pass link for faster access. A transcript and audio playback will be made available on the company's website after the call. This filing is a re-upload of an earlier intimation that was not visible on BSE.
A routine pre-results announcement — no direct impact on the stock price, but investors should track the Q4 FY2025 numbers and management commentary for cues on growth, margins, and outlook.